A Promising Antibiotic for a Deadly Infection Is Sending Paratek Pharma’s Stock Soaring – Sy Mukherjee Apr 04, 2017


A silver foil strip with white medicine tablets, displayed

There’s a strong need for new antibiotics. Photograph by Frank Bienewald LightRocket via Getty Images

Paratek Pharmaceuticals is on a roll.

The Boston-based drug maker saw shares fly as much as 31% in Tuesday trading after unveiling promising clinical trial results for an experimental antibiotic. This is the second late-stage study success for the treatment, omadacycline, and will help the firm hit its goal of filing marketing approval in both the U.S. and Europe next year. And it comes just one week after a collaboration with drug giant Allergan (agn, +0.32%) produced some impressive data for an acne drug candidate.

Article continues:

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s